• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of surgeon experience in the outcome of transurethral resection of bladder tumors.外科医生经验在经尿道膀胱肿瘤切除结果中的作用。
Urol Ann. 2020 Oct-Dec;12(4):341-346. doi: 10.4103/UA.UA_138_19. Epub 2020 Oct 15.
2
Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.高质量白光经尿道膀胱肿瘤切除术(GQ-WLTURBT)结合经验丰富的外科医生进行完整切除并获得逼尿肌,可降低新非肌肉浸润性膀胱癌的早期复发率:跨时间和地点的验证以及基准建议。
BJU Int. 2012 Jun;109(11):1666-73. doi: 10.1111/j.1464-410X.2011.10571.x. Epub 2011 Nov 1.
3
The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.经尿道切除原发性pT1膀胱肿瘤后病理标本中逼尿肌的存在情况及其与术者经验的关系。
Can J Urol. 2012 Oct;19(5):6459-64.
4
Surgeon experience in second-look transurethral resection of bladder cancer - a prospective study.外科医生在膀胱癌二次经尿道电切术中的经验——一项前瞻性研究。
Actas Urol Esp (Engl Ed). 2024 Jul-Aug;48(6):448-453. doi: 10.1016/j.acuroe.2023.12.007. Epub 2023 Dec 29.
5
Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?高级别T1期膀胱肿瘤患者首次与第二次经尿道膀胱肿瘤切除术之间的时间间隔:它是残余肿瘤检测的危险因素吗?
Urol Int. 2013;91(2):182-6. doi: 10.1159/000350512. Epub 2013 Jun 6.
6
Repeated transurethral resection for non-muscle invasive bladder cancer.非肌层浸润性膀胱癌的重复经尿道切除术
Int J Clin Exp Med. 2015 Jan 15;8(1):1416-9. eCollection 2015.
7
The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.T1 非肌肉浸润性膀胱癌经尿道膀胱肿瘤电切术再分期对生存参数的影响:系统评价和荟萃分析。
J Endourol. 2020 Aug;34(8):795-804. doi: 10.1089/end.2020.0301. Epub 2020 Jun 3.
8
Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria.经尿道膀胱肿瘤切除术治疗 T1 期膀胱癌的围手术期结局:基于患者、肿瘤和外科医生标准的质量评估。
World J Urol. 2021 Nov;39(11):4159-4165. doi: 10.1007/s00345-021-03765-8. Epub 2021 Jun 23.
9
Transurethral resection of bladder tumor and the need for re-transurethral resection of bladder tumor: time to change our practice?经尿道膀胱肿瘤切除术和再次经尿道膀胱肿瘤切除术的需求:是时候改变我们的实践了吗?
Curr Opin Urol. 2020 May;30(3):370-376. doi: 10.1097/MOU.0000000000000751.
10
Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.新诊断的 T1 期膀胱癌行二次经尿道膀胱肿瘤电切术的治疗获益:单中心经验。
Int Urol Nephrol. 2019 Aug;51(8):1335-1342. doi: 10.1007/s11255-019-02172-8. Epub 2019 May 25.

引用本文的文献

1
Recent Advances and Emerging Innovations in Transurethral Resection of Bladder Tumor (TURBT) for Non-Muscle Invasive Bladder Cancer: A Comprehensive Review of Current Literature.非肌层浸润性膀胱癌经尿道膀胱肿瘤切除术(TURBT)的最新进展与新兴创新:当前文献综述
Res Rep Urol. 2025 Mar 14;17:69-85. doi: 10.2147/RRU.S386026. eCollection 2025.
2
A Procedural Checklist for Transurethral Resection of Bladder Tumors (TURBT) Enhances Operative Dictation and Assesses Surgeon Accuracy of Tumor Characteristic Predictions.经尿道膀胱肿瘤切除术(TURBT)的操作检查表可提高手术记录质量并评估外科医生对肿瘤特征预测的准确性。
Bladder Cancer. 2023 Dec 13;9(4):335-344. doi: 10.3233/BLC-230074. eCollection 2023.

本文引用的文献

1
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2016 年更新版。
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
2
International variations in bladder cancer incidence and mortality.膀胱癌发病率和死亡率的国际差异。
Eur Urol. 2014 Jul;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001. Epub 2013 Oct 16.
3
The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.经尿道切除原发性pT1膀胱肿瘤后病理标本中逼尿肌的存在情况及其与术者经验的关系。
Can J Urol. 2012 Oct;19(5):6459-64.
4
Management of non-muscle-invasive (superficial) bladder cancer.非肌肉浸润性(浅表性)膀胱癌的治疗。
Semin Oncol. 2012 Oct;39(5):559-72. doi: 10.1053/j.seminoncol.2012.08.001.
5
The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.膀胱癌行扩大经尿道膀胱肿瘤切除术(TURBT)的价值。
BJU Int. 2012 Jul;110(2 Pt 2):E76-9. doi: 10.1111/j.1464-410X.2011.10904.x. Epub 2012 Feb 7.
6
Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.高质量白光经尿道膀胱肿瘤切除术(GQ-WLTURBT)结合经验丰富的外科医生进行完整切除并获得逼尿肌,可降低新非肌肉浸润性膀胱癌的早期复发率:跨时间和地点的验证以及基准建议。
BJU Int. 2012 Jun;109(11):1666-73. doi: 10.1111/j.1464-410X.2011.10571.x. Epub 2011 Nov 1.
7
Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer.非肌层浸润性膀胱癌患者再分期时二次经尿道电切术的评价。
J Endourol. 2010 Dec;24(12):2047-50. doi: 10.1089/end.2010.0319. Epub 2010 Oct 8.
8
Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives.非肌层浸润性膀胱癌的二次切除术:当前作用与未来展望
Eur Urol. 2010 Aug;58(2):191-2. doi: 10.1016/j.eururo.2010.04.019. Epub 2010 Apr 21.
9
Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.在首次经尿道膀胱肿瘤整块切除标本中,逼尿肌中的肿瘤组织是切除质量的替代标志物,可预测早期复发风险,并且依赖于术者经验。
Eur Urol. 2010 May;57(5):843-9. doi: 10.1016/j.eururo.2009.05.047. Epub 2009 Jun 6.
10
Quality control in transurethral resection of bladder tumours.膀胱肿瘤经尿道切除术的质量控制
BJU Int. 2008 Nov;102(9 Pt B):1242-6. doi: 10.1111/j.1464-410X.2008.07966.x.

外科医生经验在经尿道膀胱肿瘤切除结果中的作用。

Role of surgeon experience in the outcome of transurethral resection of bladder tumors.

作者信息

Ali Mohamed Hassan, Eltobgy Ahmed, Ismail Iman Yehia, Ghobish Ammar

机构信息

Department of Urology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

出版信息

Urol Ann. 2020 Oct-Dec;12(4):341-346. doi: 10.4103/UA.UA_138_19. Epub 2020 Oct 15.

DOI:10.4103/UA.UA_138_19
PMID:33776330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7992518/
Abstract

PURPOSE

The purpose of the study is to assess the quality of transurethral resection of bladder tumors (TURBTs) performed by "senior" and "junior" urologists in terms of detrusor muscle (DM) presence at the initial resection and presence of missed and residual tumors at second-look TURBT.

PATIENTS AND METHODS

An analytic prospective cohort study included 171 patients with stage T1 and Ta bladder cancer who had undergone an initial TURBT. Patients were divided into two groups according to surgeon experience. Group 1 (116 patients) operated on by senior surgeons (consultants and trainees in year 5 or 6) and Group 2 (55 patients) operated on by junior surgeons (trainees below year 5). All patients underwent second-look TURBT (by a senior urologist) within 2-6 weeks after the initial resection. The outcome of the initial and re-TURBT represented with regard to the surgeon experience.

RESULTS

There is a statistically significant difference between senior and junior surgeons regarding the presence or absence of DM in the initial resection ( = 0.001). A significant relation between the presence of residual tumors in re thermodynamic uncertainty relation (TUR) in relation to the initial operator was found ( = 0.03). Re-TURBT of patients in Group 1 (initially operated on by experienced surgeons) revealed that 57.7% had tumor-free resection while 36.2% had residual tumors, 5.2% had missed lesion and only 0.9% had concurrent residual and missed tumors. In contrast, from Group 2 (55 patients operated by junior surgeons) 47.3% had residual tumor, 21.8% had missed lesions, and 9.1% had concurrent residual and missed tumors in re-TUR.

CONCLUSIONS

Nonmuscle invasive bladder cancer treated with TURBT should be managed as any other major oncologic procedure. TURBT should be performed by an experienced surgeon or with very close supervision when done by training urologist.

摘要

目的

本研究旨在评估“资深”和“初级”泌尿外科医生进行经尿道膀胱肿瘤切除术(TURBT)的质量,评估指标包括初次切除时逼尿肌(DM)的存在情况以及二次经尿道膀胱肿瘤切除术时漏诊和残留肿瘤的情况。

患者与方法

一项分析性前瞻性队列研究纳入了171例T1期和Ta期膀胱癌患者,这些患者均接受了初次TURBT。根据外科医生的经验将患者分为两组。第1组(116例患者)由资深外科医生(顾问医生以及第5或6年的实习医生)进行手术,第2组(55例患者)由初级外科医生(第5年以下的实习医生)进行手术。所有患者在初次切除术后2 - 6周内接受二次经尿道膀胱肿瘤切除术(由资深泌尿外科医生进行)。根据外科医生的经验呈现初次和再次TURBT的结果。

结果

资深和初级外科医生在初次切除时DM的有无方面存在统计学显著差异(P = 0.001)。发现再次经尿道膀胱肿瘤切除术(TUR)中残留肿瘤的存在与初次手术医生之间存在显著关联(P = 0.03)。第1组(最初由经验丰富的外科医生进行手术)患者的再次TURBT显示,57.7%的患者切除无肿瘤,36.2%有残留肿瘤,5.2%有漏诊病变,仅有0.9%同时存在残留和漏诊肿瘤。相比之下,第2组(55例由初级外科医生进行手术的患者)在再次TUR中,47.3%有残留肿瘤,21.8%有漏诊病变,9.1%同时存在残留和漏诊肿瘤。

结论

采用TURBT治疗的非肌层浸润性膀胱癌应如同其他重大肿瘤手术一样进行管理。TURBT应由经验丰富的外科医生进行,或者在泌尿外科实习医生进行手术时进行非常密切的监督。